Considering the relatively limited sensitivity of individual detection, we further performed the evaluation of the diagnostic performances of all possible combinations of serum CST1 with traditional tumor markers, CA125 and HE4, for patients with early EC. The gene discussed is WFDC2; the disease is neoplasm.